349 related articles for article (PubMed ID: 21690566)
21. c-Myc Represses Tumor-Suppressive microRNAs, let-7a, miR-16 and miR-29b, and Induces Cyclin D2-Mediated Cell Proliferation in Ewing's Sarcoma Cell Line.
Kawano M; Tanaka K; Itonaga I; Iwasaki T; Tsumura H
PLoS One; 2015; 10(9):e0138560. PubMed ID: 26393798
[TBL] [Abstract][Full Text] [Related]
22. Extracellular vesicle (ECV)-modified polyethylenimine (PEI) complexes for enhanced siRNA delivery in vitro and in vivo.
Zhupanyn P; Ewe A; Büch T; Malek A; Rademacher P; Müller C; Reinert A; Jaimes Y; Aigner A
J Control Release; 2020 Mar; 319():63-76. PubMed ID: 31866504
[TBL] [Abstract][Full Text] [Related]
23. miR-634 Activates the Mitochondrial Apoptosis Pathway and Enhances Chemotherapy-Induced Cytotoxicity.
Fujiwara N; Inoue J; Kawano T; Tanimoto K; Kozaki K; Inazawa J
Cancer Res; 2015 Sep; 75(18):3890-901. PubMed ID: 26216549
[TBL] [Abstract][Full Text] [Related]
24. Tumor suppressors miR-143 and miR-145 and predicted target proteins API5, ERK5, K-RAS, and IRS-1 are differentially expressed in proximal and distal colon.
Pekow J; Meckel K; Dougherty U; Butun F; Mustafi R; Lim J; Crofton C; Chen X; Joseph L; Bissonnette M
Am J Physiol Gastrointest Liver Physiol; 2015 Feb; 308(3):G179-87. PubMed ID: 25477374
[TBL] [Abstract][Full Text] [Related]
25. Suppression of SIRT6 by miR-33a facilitates tumor growth of glioma through apoptosis and oxidative stress resistance.
Chang M; Qiao L; Li B; Wang J; Zhang G; Shi W; Liu Z; Gu N; Di Z; Wang X; Tian Y
Oncol Rep; 2017 Aug; 38(2):1251-1258. PubMed ID: 28677777
[TBL] [Abstract][Full Text] [Related]
26. Involvement of microRNA-141-3p in 5-fluorouracil and oxaliplatin chemo-resistance in esophageal cancer cells via regulation of PTEN.
Jin YY; Chen QJ; Xu K; Ren HT; Bao X; Ma YN; Wei Y; Ma HB
Mol Cell Biochem; 2016 Nov; 422(1-2):161-170. PubMed ID: 27644195
[TBL] [Abstract][Full Text] [Related]
27. Amphiphilic nanocarrier-induced modulation of PLK1 and miR-34a leads to improved therapeutic response in pancreatic cancer.
Gibori H; Eliyahu S; Krivitsky A; Ben-Shushan D; Epshtein Y; Tiram G; Blau R; Ofek P; Lee JS; Ruppin E; Landsman L; Barshack I; Golan T; Merquiol E; Blum G; Satchi-Fainaro R
Nat Commun; 2018 Jan; 9(1):16. PubMed ID: 29295989
[TBL] [Abstract][Full Text] [Related]
28. MicroRNA miR-4779 suppresses tumor growth by inducing apoptosis and cell cycle arrest through direct targeting of PAK2 and CCND3.
Koo KH; Kwon H
Cell Death Dis; 2018 Jan; 9(2):77. PubMed ID: 29362401
[TBL] [Abstract][Full Text] [Related]
29. Suppression of human colon tumor growth by adenoviral vector-mediated NK4 expression in an athymic mouse model.
Jie JZ; Wang JW; Qu JG; Hung T
World J Gastroenterol; 2007 Apr; 13(13):1938-46. PubMed ID: 17461494
[TBL] [Abstract][Full Text] [Related]
30. Specific microRNA-mRNA Regulatory Network of Colon Cancer Invasion Mediated by Tissue Kallikrein-Related Peptidase 6.
Sells E; Pandey R; Chen H; Skovan BA; Cui H; Ignatenko NA
Neoplasia; 2017 May; 19(5):396-411. PubMed ID: 28431272
[TBL] [Abstract][Full Text] [Related]
31. Identification of stemonamide synthetic intermediates as a novel potent anticancer drug with an apoptosis-inducing ability.
Li YY; Wang YY; Taniguchi T; Kawakami T; Baba T; Ishibashi H; Mukaida N
Int J Cancer; 2010 Jul; 127(2):474-84. PubMed ID: 19921695
[TBL] [Abstract][Full Text] [Related]
32. A prostate cancer-targeted polyarginine-disulfide linked PEI nanocarrier for delivery of microRNA.
Zhang T; Xue X; He D; Hsieh JT
Cancer Lett; 2015 Sep; 365(2):156-65. PubMed ID: 26054847
[TBL] [Abstract][Full Text] [Related]
33. Antibody-mediated delivery of anti-KRAS-siRNA in vivo overcomes therapy resistance in colon cancer.
Bäumer S; Bäumer N; Appel N; Terheyden L; Fremerey J; Schelhaas S; Wardelmann E; Buchholz F; Berdel WE; Müller-Tidow C
Clin Cancer Res; 2015 Mar; 21(6):1383-94. PubMed ID: 25589625
[TBL] [Abstract][Full Text] [Related]
34. D-SP5 Peptide-Modified Highly Branched Polyethylenimine for Gene Therapy of Gastric Adenocarcinoma.
Li X; Xie Z; Xie C; Lu W; Gao C; Ren H; Ying M; Wei X; Gao J; Su B; Ren Y; Liu M
Bioconjug Chem; 2015 Aug; 26(8):1494-503. PubMed ID: 26052814
[TBL] [Abstract][Full Text] [Related]
35. RNAi-mediated gene-targeting through systemic application of polyethylenimine (PEI)-complexed siRNA in vivo.
Urban-Klein B; Werth S; Abuharbeid S; Czubayko F; Aigner A
Gene Ther; 2005 Mar; 12(5):461-6. PubMed ID: 15616603
[TBL] [Abstract][Full Text] [Related]
36. Bioreducible polyethylenimine-delivered siRNA targeting human telomerase reverse transcriptase inhibits HepG2 cell growth in vitro and in vivo.
Xia W; Wang P; Lin C; Li Z; Gao X; Wang G; Zhao X
J Control Release; 2012 Feb; 157(3):427-36. PubMed ID: 22036880
[TBL] [Abstract][Full Text] [Related]
37. MicroRNA-33a functions as a bone metastasis suppressor in lung cancer by targeting parathyroid hormone related protein.
Kuo PL; Liao SH; Hung JY; Huang MS; Hsu YL
Biochim Biophys Acta; 2013 Jun; 1830(6):3756-66. PubMed ID: 23458685
[TBL] [Abstract][Full Text] [Related]
38. Liposome-polyethylenimine complexes (DPPC-PEI lipopolyplexes) for therapeutic siRNA delivery in vivo.
Ewe A; Panchal O; Pinnapireddy SR; Bakowsky U; Przybylski S; Temme A; Aigner A
Nanomedicine; 2017 Jan; 13(1):209-218. PubMed ID: 27553077
[TBL] [Abstract][Full Text] [Related]
39. miR-451 suppresses bladder cancer cell migration and invasion via directly targeting c-Myc.
Wang J; Zhao X; Shi J; Pan Y; Chen Q; Leng P; Wang Y
Oncol Rep; 2016 Oct; 36(4):2049-58. PubMed ID: 27571748
[TBL] [Abstract][Full Text] [Related]
40. miRomics and Proteomics Reveal a miR-296-3p/PRKCA/FAK/Ras/c-Myc Feedback Loop Modulated by HDGF/DDX5/β-catenin Complex in Lung Adenocarcinoma.
Fu Q; Song X; Liu Z; Deng X; Luo R; Ge C; Li R; Li Z; Zhao M; Chen Y; Lin X; Zhang Q; Fang W
Clin Cancer Res; 2017 Oct; 23(20):6336-6350. PubMed ID: 28751441
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]